REIMAGINE 2 Study App
Medical
Free
This app is intended to collect important study-related information from individuals participating in the REIMAGINE 2 clinical study.
The REIMAGINE 2 NN9388-4896 Study App will collect information such as doses taken, low blood sugar episodes, participant reported outcomes and more for the clinical study.
Sites participating in the clinical trial are required to create accounts for each participant in the study app before participants can log into the App
Ratings & Reviews
This app hasn’t received enough ratings or reviews to display an overview.
OS patch integration
The developer, ERT,INC, indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy .
Data Not Linked to You
The following data may be collected but it is not linked to your identity:
- Health & Fitness
Accessibility
The developer has not yet indicated which accessibility features this app supports. Learn More
Information
- Seller
- ERT, INC
- Size
- 90.4 MB
- Category
- Medical
- Compatibility
Requires iOS 12.0 or later.
- iPhone
Requires iOS 12.0 or later. - iPad
Requires iPadOS 12.0 or later. - iPod touch
Requires iOS 12.0 or later.
- Languages
- English
- Age Rating
13+
- 13+
- Infrequent
Medical Treatment information
- Copyright
- © Novo Nordisk, Clario, Medical Outcomes Trust, Quality Metric Inc., Health Psychology Research Ltd., TransCelerate Biopharma Ltd., National Institute of Mental Health (NIMH), Dr. Michelle Dalton